I787 provides signals for c-Kit receptor internalization and functionality that control mast cell survival and development

Blood

Volumn 116, Issue 15, 2010, Pages 2665-2675

  Orinska, Zane ^a,b   Föger, Niko ^a,b   Huber, Michael ^c   Marschall, Julia ^c   Mirghomizadeh, Farhad ^a   Du, Xin ^d   Scheller, Marina ^e   Rosenstiel, Philip ^f   Goldmann, Torsten ^a   Bollinger, Annalena ^a,b   Beutler, Bruce A ^d   Bulfone Paus, Silvia ^a,b  

^a RESEARCH CENTER BORSTEL   (Germany)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c RWTH AACHEN UNIVERSITY   (Germany)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

^e MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^f UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CBL PROTEIN; ISOLEUCINE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHENYLALANINE; STEM CELL FACTOR RECEPTOR; SYNAPTOPHYSIN; CBL PROTEIN, MOUSE; INTERLEUKIN 3; MUTANT PROTEIN; PRIMER DNA; STEM CELL FACTOR;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOPHOSPHORYLATION; BONE MARROW; CELL MATURATION; CELL SURVIVAL; CONNECTIVE TISSUE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME ACTIVATION; EXON; LIGAND BINDING; MAST CELL; MAST CELL DEGRANULATION; MOUSE; MUCOSA; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UBIQUITINATION; AMINO ACID SEQUENCE; ANIMAL; C3H MOUSE; C57BL MOUSE; CELL DIFFERENTIATION; CELL LINE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; GENETICS; IN VITRO STUDY; METABOLISM; MUTANT MOUSE STRAIN; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; SITE DIRECTED MUTAGENESIS;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; BASE SEQUENCE; CELL DIFFERENTIATION; CELL LINE; CELL SURVIVAL; DNA PRIMERS; IN VITRO TECHNIQUES; INTERLEUKIN-3; ISOLEUCINE; MAST CELLS; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MUTAGENESIS, SITE-DIRECTED; MUTANT PROTEINS; POINT MUTATION; PROTO-ONCOGENE PROTEINS C-CBL; PROTO-ONCOGENE PROTEINS C-KIT; SIGNAL TRANSDUCTION; STEM CELL FACTOR;

EID: 77957950043     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-06-228460     Document Type: Article

References (46)

1. Grimbaldeston MA, Metz M, Yu M, Tsai M, Galli SJ. Effector and potential immunoregulatory roles of mast cells in IgE-associated acquired immune responses. Curr Opin Immunol. 2006;18(6):751-760. (Pubitemid 44642318)
2. Sayed BA, Christy A, Quirion MR, Brown MA. The master switch: the role of mast cells in autoimmunity and tolerance. Annu Rev Immunol. 2008;26:705-739. (Pubitemid 351600390)
3. Metz M, Grimbaldeston MA, Nakae S, Piliponsky AM, Tsai M, Galli SJ. Mast cells in the promotion and limitation of chronic inflammation. Immunol Rev. 2007;217:304-328. (Pubitemid 46718153)
4. Mekori YA, Metcalfe DD. Mast cells in innate immunity. Immunol Rev. 2000;173:131-140.
5. Dawicki W, Marshall JS. New and emerging roles for mast cells in host defence. Curr Opin Immunol. 2007;19(1):31-38. (Pubitemid 46073696)
6. Chen CC, Grimbaldeston MA, Tsai M, Weissman IL, Galli SJ. Identification of mast cell progenitors in adult mice. Proc Natl Acad Sci U S A. 2005;102(32):11408-11413. (Pubitemid 41153833)
7. Okayama Y, Kawakami T. Development, migration, and survival of mast cells. Immunol Res. 2006;34(2):97-115. (Pubitemid 43997964)
8. Meininger CJ, Yano H, Rottapel R, Bernstein A, Zsebo KM, Zetter BR. The c-kit receptor ligand functions as a mast cell chemoattractant. Blood. 1992;79(4):958-963.
9. Zhang Z, Zhang R, Joachimiak A, Schlessinger J, Kong XP. Crystal structure of human stem cell factor: implication for stem cell factor receptor dimerization and activation. Proc Natl Acad Sci U S A. 2000;97(14):7732-7737. (Pubitemid 30460716)
10. Yuzawa S, Opatowsky Y, Zhang Z, Mandiyan V, Lax I, Schlessinger J. Structural basis for activation of the receptor tyrosine kinase KIT by stem cell factor. Cell. 2007;130(2):323-334. (Pubitemid 47081138)
11. Mol CD, Lim KB, Sridhar V, et al. Structure of a c-Kit product complex reveals the basis for kinase transactivation. J Biol Chem. 2003;278(34):31461- 31464. (Pubitemid 37048320)
12. Mol CD, Dougan DR, Schneider TR, et al. Structural basis for the autoinhibition and STI-571 inhibition of c-Kit tyrosine kinase. J Biol Chem. 2004;279(30):31655-31663.
13. Roskoski R Jr. Structure and regulation of Kit protein tyrosine kinase-the stem cell factor receptor. Biochem Biophys Res Commun. 2005;338(3):1307-1315.
14. Roskoski R Jr. Signaling by Kit protein-tyrosine kinase - the stem cell factor receptor. Biochem Biophys Res Commun. 2005;337(1):1-13. (Pubitemid 41393751)
15. Lennartsson J, Jelacic T, Linnekin D, Shivakrupa R. Normal and oncogenic forms of the receptor tyrosine kinase kit. Stem Cells. 2005;23(1):16-43. (Pubitemid 40105289)
16. Rönnstrand L. Signal transduction via the stem cell factor receptor/c-Kit. Cell Mol Life Sci. 2004;61(19-20):2535-2548. (Pubitemid 39586516)
17. Giebel LB, Spritz RA. Mutation of the KIT (mast/stem cell growth factor receptor) protooncogene in human piebaldism. Proc Natl Acad Sci U S A. 1991;88(19):8696-8699.
18. Ward KA, Moss C, Sanders DSA. Human piebaldism: relationship between phenotype and site of kit gene mutation. Brit J Dermatol. 1995;132(6):929-935.
19. Longley BJ, Tyrrell L, Lu SZ, et al. Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm. Nat Genet. 1996;12(3):312-314. (Pubitemid 26080092)
20. Metcalfe DD. Mast cells and mastocytosis. Blood. 2008;112(4):946-956.
21. Galanos C, Luderitz O. Electrodialysis of lipopolysaccharides and their conversion to uniform salt forms. Eur J Biochem. 1975;54(2):603-610.
22. Yoshimura T, Kaneuchi T, Miura T, Kimura M. Kinetic analysis of the fluorescence reaction of histamine with orthophthalaldehyde. Anal Biochem. 1987;164(1):132-137.
23. Berger SA. Measuring mast cell degranulation. In: Lefkovits I, ed. Immunology Methods Manual. Vol 3. London: Academic Press; 1997:1436-1440.
24. Orinska Z, Maurer M, Mirghomizadeh F, et al. IL-15 constrains mast cell-dependent antibacterial defenses by suppressing chymase activities. Nat Med. 2007;13(8):927-934. (Pubitemid 47222042)
25. Turner AM, Bennett LG, Lin NL, et al. Identification and characterization of a soluble c-kit receptor produced by human hematopoietic cell lines. Blood. 1995;85(8):2052-2058.
26. Dahlen DD, Lin NL, Liu YC, Broudy VC. Soluble c-kit receptor blocks stem cell factor bioactivity in vitro. Leuk Res. 2001;25(5):413-421.
27. Cruz AC, Frank BT, Edwards ST, Dazin PF, Peschon JJ, Fang KC. Tumor necrosis factor-α-converting enzyme controls surface expression of c-Kit and survival of embryonic stem cell-derived mast cells. J Biol Chem. 2004;279(7):5612-5620.
28. Huber M, Helgason CD, Scheid MP, Duronio V, Humphries RK, Krystal G. Targeted disruption of SHIP leads to Steel factor-induced degranulation of mast cells. EMBO J. 1998;17(24):7311-7319. (Pubitemid 29002700)
29. Zeng S, Xu Z, Lipkowitz S, Longley JB. Regulation of stem cell factor receptor signaling by Cbl family proteins (Cbl-b/c-Cbl). Blood. 2005;105(1):226-232. (Pubitemid 40053087)
30. Masson K, Heiss E, Band H, Rönnstrand L. Direct binding of Cbl to Tyr568 and Tyr936 of the stem cell factor receptor/c-Kit is required for ligandinduced ubiquitination, internalization and degradation. Biochem J. 2006;399(1):59-67. (Pubitemid 44505407)
31. Duttlinger R, Manova K, Berrozpe G, et al. The Wsh and Ph mutations affect the c-kit expression profile: c-kit misexpression in embryogenesis impairs melanogenesis in Wsh and Ph mutant mice. Proc Natl Acad Sci U S A. 1995;92(9):3754-3758.
32. Berrozpe G, Timokhina I, Yukl S, et al. The Wsh, W57, and Ph Kit expression mutations define tissue-specific control elements located between -23 and -154 kb upstream of Kit. Blood. 1999;94(8):2658-2666. (Pubitemid 29477294)
33. Nigrovic PA, Gray DH, Jones T, et al. Genetic inversion in mast cell-deficient (W(sh)) mice interrupts corin and manifests as hematopoietic and cardiac aberrancy. Am J Pathol. 2008;173(6):1693-1701.
34. Grimbaldeston MA, Chen CC, Piliponsky AM, Tsai M, Tam SY, Galli SJ. Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo. Am J Pathol. 2005;167(3):835-848. (Pubitemid 41216366)
35. Ruan H-B, Zhang N, Gao X. Identification of a novel point mutation of mouse proto-oncogene c-kit through N-ethyl-N-nitrosourea mutagenesis. Genetics. 2005;169(2):819-831. (Pubitemid 40404313)
36. Kimura Y, Jones N, Klüppel M, et al. Targeted mutations of the juxtamembrane tyrosines in the Kit receptor tyrosine kinase selectively affect multiple cell lineages. Proc Natl Acad Sci U S A. 2004;101(16):6015-6020. (Pubitemid 38520520)
37. Kissel H, Timokhina I, Hardy MP, et al. Point mutation in kit receptor tyrosine kinase reveals essential roles for kit signaling in spermatogenesis and oogenesis without affecting other kit responses. EMBO J. 2000;19(6):1312-1326. (Pubitemid 30151027)
38. Agosti V, Corbacioglu S, Ehlers I, et al. Critical role for Kit-mediated Src kinase but not PI 3-kinase signaling in pro T and pro B cell development. J Exp Med. 2004;199(6):867-878. (Pubitemid 38375206)
39. Yee NS, Langen H, Besmer P. Mechanism of kit ligand, phorbol ester, and calcium-induced down-regulation of c-kit receptors in mast cells. J Biol Chem. 1993;268(19):14189-14201. (Pubitemid 23195541)
40. Mayerhofer M, Gleixner KV, Hoelbl A, et al. Unique effects of KIT D816V in BaF3 cells: induction of cluster formation, histamine synthesis, and early mast cell differentiation antigens. J. Immunol. 2008;180(8):5466-5476.
41. Wandzioch E, Edling CE, Palmer RH, Carlsson L, Hallberg B. Activation of the MAP kinase pathway by c-kit is PI-3 kinase dependent in hematopoietic progenitor/stem cell lines. Blood. 2004;104(1):51-57. (Pubitemid 38879837)
42. Edling CE, Hallberg B. c-Kit - a hematopoietic cell essential receptor tyrosine kinase. Int J Biochem Cell Biol. 2007;39(11):1995-1998. (Pubitemid 47376824)
43. Miaczynska M, Pelkmans L, Zerial M. Not just a sink: endosomes in control of signal transduction. Curr Opin Cell Biol. 2004;16(4):400-406. (Pubitemid 38903146)
44. Hoeller D, Volarevic S, Dikic I. Compartmentalization of growth factor receptor signalling. Curr Opin Cell Biol. 2005;17(2):107-111. (Pubitemid 40380931)
45. Oksvold MP, Skarpen E, Wierød L, Paulsen RE, Huitfeldt HS. Re-localization of activated EGF receptor and its signal transducers to multivesicular compartments downstream of early endosomes in response to EGF. Eur J Cell Biol. 2001;80(4):285-294. (Pubitemid 32390146)
46. Taub N, Teis D, Ebner HL, Hess MW, Huber LA. Late endosomal traffic of the epidermal growth factor receptor ensures spatial and temporal fidelity of mitogen-activated protein kinase signaling. Mol Biol Cell. 2007;18(12):4698- 4710. (Pubitemid 350246673)